| Date Filed | Type | Description |
| 07/05/2023 |
4
| Charles Faith L. (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 100,000 options to buy
@ $1.14, valued at
$114k
|
|
| 07/05/2023 |
4
| Jin David (Interim PFO and COO) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 250,000 options to buy
@ $1.14, valued at
$285k
|
|
| 07/05/2023 |
4
| ROSENWALD LINDSAY A MD (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 100,000 options to buy
@ $1.14, valued at
$114k
|
|
| 07/05/2023 |
4
| KRANZLER JAY D (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 100,000 options to buy
@ $1.14, valued at
$114k
|
|
| 07/05/2023 |
4
| Oltmans Curtis Gale (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 100,000 options to buy
@ $1.14, valued at
$114k
|
|
| 07/05/2023 |
4
| Herskowitz Neil (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 100,000 options to buy
@ $1.14, valued at
$114k
|
|
| 07/03/2023 |
4
| MacLean Alexandra (CEO) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 800,000 options to buy
@ $1.14, valued at
$912k
|
|
| 04/04/2023 |
4
| Fortress Biotech, Inc. (10% Owner) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 52,419 shares
@ $0 |
|
| 01/04/2023 |
4
| Fortress Biotech, Inc. (10% Owner) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 90,909 shares
@ $0
Granted 231,316 shares
@ $0 |
|
| 10/13/2022 |
4
| InvaGen Pharmaceuticals, Inc. (10% Owner) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Sold 388,888 shares
@ $7.714, valued at
$3M
|
|
| 08/03/2022 |
3
| MacLean Alexandra (CEO) has filed a Form 3 on AVENUE THERAPEUTICS, INC. |
| 05/25/2022 |
3
| Jin David (Int. PEO, Int. PFO, and COO) has filed a Form 3 on AVENUE THERAPEUTICS, INC. |
| 05/17/2022 |
3
| Charles Faith L. (Director) has filed a Form 3 on AVENUE THERAPEUTICS, INC. |
| 12/21/2021 |
4
| KRANZLER JAY D (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 49,020 shares
@ $0
Granted 20,000 shares
@ $0 |
|
| 12/21/2021 |
4
| Herskowitz Neil (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 49,020 shares
@ $0
Granted 20,000 shares
@ $0 |
|
| 12/21/2021 |
4
| Oltmans Curtis Gale (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 49,020 shares
@ $0 |
|
| 12/21/2021 |
3
| Oltmans Curtis Gale (Director) has filed a Form 3 on AVENUE THERAPEUTICS, INC. |
| 12/20/2021 |
4
| Lu Lucy (President, CEO) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 411,616 shares
@ $0 |
|
| 12/20/2021 |
4
| Vazzano Joseph Walter (CFO) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 100,505 shares
@ $0 |
|
| 09/15/2021 |
4
| Vazzano Joseph Walter (CFO) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Sold 7,160 shares
@ $1.62, valued at
$11.6k
|
|
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| KRANZLER JAY D (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 06/16/2020 |
4
| Herskowitz Neil (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 03/10/2020 |
4
| Vazzano Joseph Walter (CFO) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Bought 1,400 shares
@ $7.99, valued at
$11.2k
Bought 100 shares
@ $7.97, valued at
$797
Bought 1,889 shares
@ $7.94, valued at
$15k
|
|
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Vazzano Joseph Walter (CFO) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Bought 1,200 shares
@ $9.09, valued at
$10.9k
|
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
4
| Vazzano Joseph Walter (CFO) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 22,727 restricted stock units
@ $0 |
|
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2019 |
3
| InvaGen Pharmaceuticals, Inc. (10% Owner) has filed a Form 3 on AVENUE THERAPEUTICS, INC. |
| 09/16/2019 |
4
| Ingram Elizabeth Garrett (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Bought 16,000 shares
@ $6.27, valued at
$100.3k
|
|
| 08/28/2019 |
4
| KRANZLER JAY D (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 08/28/2019 |
4
| Herskowitz Neil (Director) has filed a Form 4 on AVENUE THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $0 |
|
|